Diagnostic value of oral prednisolone test for chronic obstructive pulmonary disorders

Annals of Family Medicine

Volumn 9, Issue 2, 2011, Pages 104-109

  Broekhuizen, Berna D L ^a   Sachs, Alfred P E ^a   Moons, Karel G M ^a   Cheragwandi, Samir A A ^b   Sinninghe Damsté, Hendrik E J ^c   Wijnands, Giel J A ^d   Verheij, Theo J M ^a   Hoes, Arno W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Stichting Koning Beatrix   (Netherlands)

^c Ziekenhuisgroep Twente   (Netherlands)

^d DEVENTER HOSPITAL   (Netherlands)

Author keywords

Asthma; COPD; Corticosteroids; Cough; Diagnostic tests; Routine

Indexed keywords

GLUCOCORTICOID; PREDNISOLONE;

ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC TEST; FORCED EXPIRATORY VOLUME; HUMAN; MIDDLE AGED; NETHERLANDS; ORAL DRUG ADMINISTRATION; RECEIVER OPERATING CHARACTERISTIC; VITAL CAPACITY;

ADMINISTRATION, ORAL; ASTHMA; DIAGNOSTIC TESTS, ROUTINE; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED; NETHERLANDS; PREDNISOLONE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; ROC CURVE; VITAL CAPACITY;

EID: 79952787568     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.1223     Document Type: Article

References (30)

1. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007; 176(6):532-555.
2. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA). http://www.ginasthma org 2010.
3. Levy ML, Quanjer PH, Booker R, Cooper BG, Holmes S, Small I. Diagnostic spirometry in primary care: Proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations. Prim Care Respir J. 2009;18(3):130-147.
4. Pennock BE, Rogers RM, McCaffree DR. Changes in measured spi-rometric indices. What is signif cant? Chest. 1981;80(1):97-99.
5. Rozas CJ, Goldman AL. Daily spirometric variability: normal subjects and subjects with chronic bronchitis with and without airf ow obstruction. Arch Intern Med. 1982;142(7):1287-1291.
6. Callahan CM, Dittus RS, Katz BP. Oral Corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. Ann Intern Med. 1991;114(3):216-223.
7. Borrill Z, Houghton C, Sullivan PJ, Sestini P. Retrospective analysis of evidence base for tests used in diagnosis and monitoring of disease in respiratory medicine. BMJ. 2003;327(7424):1136-1138.
8. Broekhuizen BD, Sachs AP, Hoes AW, et al. Undetected chronic obstructive pulmonary disease and asthma in people over 50 years with persistent cough. Br J Gen Pract. 2010;60(576):489-494.
9. Hernandez-Diaz S, Rodriguez LA. Steroids and risk of upper gastrointestinal complications. Am J Epidemiol. 2001;153(11):1089-1093.
10. Williamson HA Jr. Pulmonary function tests in acute bronchitis: evidence for reversible airway obstruction. J Fam Pract. 1987;25(3): 251-256.
11. Roberts SD, Farber MO, Knox KS, et al. FEV1/FVC ratio of 70% misclassif es patients with obstruction at the extremes of age. Chest. 2006;130(1):200-206.
12. Geijer RM, Smeele IJ, Goudswaard AN. Summary of the practice guideline 'Asthma in adults' (2nd revision) from the Dutch College of General Practitioners. Ned Tijdschr Geneeskd. 2008;152(20): 1146-1150.
13. Smeele IJ, van Weel C, Van Schayck C P, et al. NHG-standaard COPD. Huisarts Wet. 2007;50(8):362-379.
14. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948-968.
15. R: A Language and Environment for Statistical Computing, R Development Core Team. R Vienna, Austria: Foundation for Statistical Computing; 2008.
16. Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA. Pred-nisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study. Thorax. 2003;58(8):654-658.
17. Chavannes NH, Schermer T, Wouters EF, et al. Predictive value and utility of oral steroid testing for treatment of COPD in primary care: the COOPT study. Int J COPD. 2009(4);2009.
18. Rutgers SR, Postma DS, ten Hacken NHT, et al. Ongoing airway inf ammation in patients with COPD who do not currently smoke. Thorax. 2000;55(1):12-18.
19. Lapperre TS, Snoeck-Stroband JB, Gosman MM, et al. Dissociation of lung function and airway inf ammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170(5):499-504.
20. Brightling CE, Monteiro W, Ward R, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2000;356 (9240):1480-1485.
21. Beasley R, Weatherall M, Travers J, Shirtcliffe P. Time to def ne the disorders of the syndrome of COPD. Lancet. 2009;374(9691):670-672.
22. Wedzicha JA. The heterogeneity of chronic obstructive pulmonary disease. Thorax. 2000;55(8):631-632.
23. Calverley PM, Burge PS, Spencer S, Anderson JA, Jones PW. Bron-chodilator reversibility testing in chronic obstructive pulmonary disease. Thorax. 2003;58(8):659-664.
24. Tashkin D P, Celli B, Decramer M, et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J. 2008;31(4):742-750.
25. Kesten S, Rebuck AS. Is the short-term response to inhaled beta-adrenergic agonist sensitive or specif c for distinguishing between asthma and COPD? Chest. 1994;105(4):1042-1045.
26. Nisar M, Walshaw M, Earis JE, Pearson MG, Calverley PM. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease. Thorax. 1990;45(3):190-194.
27. Gross NJ. COPD: a disease of reversible air-f ow obstruction. Am Rev Respir Dis. 1986;133(5):725-726.
28. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009; 64(8):728-735.
29. Tinkelman DG, Price DB, Nordyke RJ, et al. Symptom-based questionnaire for differentiating COPD and asthma. Respiration. 2006; 73(3):296-305.
30. Price DB, Tinkelman DG, Halbert RJ, et al. Symptom-based questionnaire for identifying COPD in smokers. Respiration. 2006;73(3): 285-295.